|Home||» Products||» Pharmaceutical Formulations||» GAFTICIP|
Gafticip is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. The offered tablet contains gefitinib as an active ingredient. Gafticip works by blocking a protein to inhibit spread and growth of cancer cells. Take as directed by the doctor or follow the direction printed on the product insert. Dosage is based on patients condition.
ACE GOLDEN INTERNATIONAL All Rights Reserved.